Wird geladen...
Hydroxyurea-induced cutaneous squamous cell carcinoma: A case report
BACKGROUND: Hydroxyurea (HU) is a non-alkylating antineoplastic agent that is active in the S-phase of the cell cycle and inhibits the enzyme ribonucleoside reductase. HU is currently used to treat leukemia, sickle cell anemia, psoriasis, and chronic myeloproliferative disorders. Although HU is easy...
Gespeichert in:
| Veröffentlicht in: | World J Clin Cases |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6906572/ https://ncbi.nlm.nih.gov/pubmed/31832413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v7.i23.4091 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|